Simulations Plus Goodwill and Intangible Assets 2010-2025 | SLP
Simulations Plus goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Simulations Plus Annual Goodwill and Intangible Assets (Millions of US $) |
2024 |
$142 |
2023 |
$41 |
2022 |
$30 |
2021 |
$30 |
2020 |
$32 |
2019 |
$19 |
2018 |
$20 |
2017 |
$21 |
2016 |
$11 |
2015 |
$12 |
2014 |
$6 |
2013 |
$0 |
2012 |
$0 |
2011 |
$0 |
2010 |
$0 |
2009 |
$0 |
Simulations Plus Quarterly Goodwill and Intangible Assets (Millions of US $) |
2025-05-31 |
$62 |
2025-02-28 |
$140 |
2024-11-30 |
$141 |
2024-08-31 |
$142 |
2024-05-31 |
$39 |
2024-02-29 |
$40 |
2023-11-30 |
$40 |
2023-08-31 |
$41 |
2023-05-31 |
$29 |
2023-02-28 |
$29 |
2022-11-30 |
$29 |
2022-08-31 |
$30 |
2022-05-31 |
$30 |
2022-02-28 |
$31 |
2021-11-30 |
$29 |
2021-08-31 |
$30 |
2021-05-31 |
$30 |
2021-02-28 |
$31 |
2020-11-30 |
$31 |
2020-08-31 |
$32 |
2020-05-31 |
$32 |
2020-02-29 |
$18 |
2019-11-30 |
$18 |
2019-08-31 |
$19 |
2019-05-31 |
$19 |
2019-02-28 |
$19 |
2018-11-30 |
$20 |
2018-08-31 |
$20 |
2018-05-31 |
$20 |
2018-02-28 |
$21 |
2017-11-30 |
$21 |
2017-08-31 |
$21 |
2017-05-31 |
$10 |
2017-02-28 |
$10 |
2016-11-30 |
$11 |
2016-08-31 |
$11 |
2016-05-31 |
$11 |
2016-02-29 |
$11 |
2015-11-30 |
$11 |
2015-08-31 |
$12 |
2015-05-31 |
$12 |
2015-02-28 |
$12 |
2014-11-30 |
$12 |
2014-08-31 |
$6 |
2014-05-31 |
$6 |
2014-02-28 |
$0 |
2013-11-30 |
$0 |
2013-08-31 |
$0 |
2013-05-31 |
$0 |
2013-02-28 |
$0 |
2012-11-30 |
$0 |
2012-08-31 |
$0 |
2012-05-31 |
$0 |
2012-02-29 |
$0 |
2011-11-30 |
$0 |
2011-08-31 |
$0 |
2011-05-31 |
$0 |
2011-02-28 |
$0 |
2010-11-30 |
$0 |
2010-08-31 |
$0 |
2010-05-31 |
$0 |
2010-02-28 |
$0 |
2009-11-30 |
$0 |
2009-08-31 |
$0 |
2009-05-31 |
$0 |
2009-02-28 |
$0 |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Computer Software |
$0.285B |
$0.070B |
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|